Association of Body Composition with Outcome of Docetaxel Chemotherapy in Metastatic Prostate Cancer: A Retrospective Review-Reference-Cited by-同舟云学术

Association of Body Composition with Outcome of Docetaxel Chemotherapy in Metastatic Prostate Cancer: A Retrospective Review

Published:2015-03-30 Issue:3 Volume:10 Page:e0122047
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wu Weixin,Liu Xiandong,Chaftari Patrick,Cruz Carreras Maria Teresa,Gonzalez Carmen,Viets-Upchurch Jayne,Merriman Kelly,Tu Shi-Ming,Dalal Shalini,Yeung Sai-Ching J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer;EM Messing;The New England journal of medicine,1999

2. Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer;MR Smith;Urology,2004

3. Changes in body composition during androgen deprivation therapy for prostate cancer;MR Smith;The Journal of clinical endocrinology and metabolism,2002

4. A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database;HS Kim;BJU international,2011

5. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;IF Tannock;The New England journal of medicine,2004

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI-measured periprostatic to subcutaneous adipose tissue thickness ratio as an independent risk factor in prostate cancer patients undergoing radical prostatectomy;Scientific Reports;2024-09-08

2. Empagliflozin, a sodium‐glucose cotransporter inhibitor enhancing mitochondrial action and cardioprotection in metabolic syndrome;Journal of Cellular Physiology;2024-05-19

3. Using maximum plasma concentration (Cmax) to personalize taxane treatment and reduce toxicity;Cancer Chemotherapy and Pharmacology;2024-05-11

4. Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial;BMC Cancer;2024-04-18

5. Mitophagy modulation for the treatment of cardiovascular diseases;European Journal of Clinical Investigation;2024-03-26